Posted by Michael Wonder on 02 Jun 2025
Garadacimab in hereditary angioedema: evidence of considerable additional benefit
2 June 2025 - An indirect comparison shows a significant reduction in the monthly rate of attacks and other benefits.
Why manufacturers continue to test their active ingredients against placebo in this indication remains unclear.
